Phaos Technology Holdings (Cayman) Limited Announces Entry Into Securities Purchase Agreement for an Equity Facility of Up to US$10 Million

The facility provides optional equity funding, while requiring commitment-fee shares and satisfaction of conditions before sales can begin.

Rhea-AI Summary

Phaos Technology Holdings (Cayman) (POAS) entered into a securities purchase agreement with High West Partners for an equity facility of up to US$10 million.

The agreement, dated September 28, 2026, gives Phaos the right, but not the obligation, to sell Class A ordinary shares at prevailing market prices. Sales are subject to agreement conditions and applicable NYSE listing rules. The sale window begins when conditions for Phaos to sell and the investor to purchase are satisfied, and expires on the 36-month anniversary of that commencement date. Phaos also agreed to issue Class A ordinary shares as a commitment fee, fully earned at commencement and issued upon delivery of the first purchase notice.

2 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Major point. Forward-looking: it has not happened yet and may not happen.Up to US$10 million equity facility provides optional funding through share sales to High West Partners. 1.9× market cap
• Minor point. Forward-looking: it has not happened yet and may not happen.36-month sale window begins when commencement conditions are satisfied.

Negative

• Major point. Forward-looking: it has not happened yet and may not happen.Class A ordinary share sales at prevailing market prices would dilute existing holders.
• Minor point. Forward-looking: it has not happened yet and may not happen.Commitment-fee shares are fully earned at commencement and issued upon the first purchase notice.
• Minor pointSales remain conditional on agreement requirements and applicable NYSE listing rules.

Argus 15 min delay 2 alerts

+1.53% vs previous close $0.17 last price 30.4x rel. volume Open Argus

Details

Market Reaction – POAS

$0.16 – $0.17 Day Range

$5.45M Market Cap

On Oct 1, the day this news came out, the latest delayed price for POAS is 1.53% above the previous close. Our momentum scanner has recorded 2 alerts for this stock so far that day. The latest delayed price is $0.17. Relative volume is exceptionally heavy at 30.4x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Maximum facility amount: US$10,000,000 Facility term: 36 months

Maximum facility amount

US$10,000,000

Optional share sales at prevailing market prices

Facility term

36 months

Expires on the 36-month anniversary of the Commencement Date

Key Terms

securities purchase agreement, commitment fee

2 terms

securities purchase agreement financial

"entered into a securities purchase agreement"

A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.

commitment fee financial

"as a commitment fee"

A commitment fee is a charge a lender applies to a borrower for keeping a loan or line of credit available, even before any money is drawn. Think of it as a reservation fee for borrowing power; the borrower pays to ensure funds will be there when needed. Investors care because it adds to a company’s borrowing cost, affects cash flow and liquidity, and can signal lenders’ willingness to extend credit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SINGAPORE, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), an advanced microscopy technology company headquartered in Singapore, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”), dated as of September 28, 2026, with High West Partners LLC, a California limited liability company (the “Investor”). Under the Purchase Agreement, the Company has the right, but not the obligation, to sell to the Investor from time to time up to US$10,000,000 of its Class A ordinary shares, at prevailing market prices and subject to the terms, conditions and limitations set out in the Purchase Agreement and the applicable NYSE listing rules. The Company’s right to sell Ordinary Shares to the Investor begins on the date on which the conditions to the Company’s right to sell, and the Investor’s obligation to purchase, Ordinary Shares under the Purchase Agreement are satisfied (the “Commencement Date”), and expires on the 36-month anniversary of the Commencement Date. The Company has also agreed to issue a number of Class A ordinary shares to the Investor as a commitment fee, which will be fully earned as of the Commencement Date and issued upon the delivery of the first purchase notice.

About Phaos Technology Holdings (Cayman) Limited
Phaos Technology Holdings (Cayman) Limited is an advanced microscopy technology company. Our commitment to innovation and excellence drives us to deliver state-of-the-art microscopy products and software solutions, powered by artificial intelligence, for diverse sectors including manufacturing, biomedical, and research. Experience the difference with Phaos Technology – where innovation meets sophistication, shaping the future of optical technology. For more information, please visit www.phaostech.com.

Forward Looking Statements
This news release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that indicate future events or trends or are not statements of historical matters. These statements are based on our management’s current expectations and beliefs, as well as a number of assumptions concerning future events.
Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of our control and all of which could cause actual results to differ materially from the results discussed in the forward-looking statements. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements can be found in our reports filed with the United States Securities and Exchange Commission, which are available, free of charge, on the SEC’s website at www.sec.gov.

For more information please contact:

Company Contact:
Phaos Technology Holdings (Cayman) Limited
(65) 6250 3877
ir@phaostech.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much funding can Phaos (POAS) access under its High West Partners equity facility?

Phaos has the right, but not the obligation, to sell up to US$10,000,000 of Class A ordinary shares to High West Partners at prevailing market prices. Sales are subject to the purchase agreement's terms, conditions and limitations and applicable NYSE listing rules.

When does Phaos (POAS)'s equity facility begin and expire?

The facility begins when the conditions for Phaos to sell shares and High West Partners to purchase them are satisfied. Phaos's right to sell expires on the 36-month anniversary of that commencement date.